Legal Representation
Attorney
Robert M. Siminski/Jessica S. Sachs
USPTO Deadlines
Next Deadline
2182 days remaining
Section 8 & 9 Renewal Due (Principal Register) (20-Year) (Based on R.PRA event 2011-12-06)
Due Date
December 06, 2031
Grace Period Ends
June 06, 2032
Application History
19 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Jul 13, 2018 | C8.. | O | CANCELLED SEC. 8 (6-YR) | Loading... |
| Dec 6, 2016 | REM1 | E | COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED | Loading... |
| Oct 1, 2014 | ASGN | I | AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP | Loading... |
| Dec 6, 2011 | R.PR | A | REGISTERED-PRINCIPAL REGISTER | Loading... |
| Sep 20, 2011 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
| Sep 20, 2011 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| Aug 17, 2011 | PREV | O | LAW OFFICE PUBLICATION REVIEW COMPLETED | Loading... |
| Aug 16, 2011 | ALIE | A | ASSIGNED TO LIE | Loading... |
| Aug 3, 2011 | CNSA | O | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| Aug 2, 2011 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
| Aug 2, 2011 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| Aug 2, 2011 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | Loading... |
| Feb 3, 2011 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | Loading... |
| Feb 3, 2011 | GNRT | F | NON-FINAL ACTION E-MAILED | Loading... |
| Feb 3, 2011 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
| Feb 2, 2011 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Oct 27, 2010 | MDSM | O | NOTICE OF DESIGN SEARCH CODE MAILED | Loading... |
| Oct 26, 2010 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| Oct 26, 2010 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Additional Information
Design Mark
The mark consists of the stylized wording.
Color Claim
The color(s) orange and gray is/are claimed as a feature of the mark.
Pseudo Mark
C CARACO PHARMACEUTICAL, INC.
Disclaimers
The following terms have been disclaimed and are not claimed as part of the trademark:
General Disclaimer
"PHARMA, INC."